Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC 109555 is a selective, reversible, ATP-competitive Chk2 inhibitor (IC50 = 0.2 μM) that displays no effect on a range of other kinases including Chk1 (IC50 < 10 μM). Inhibits histone H1 phosphorylation (IC50 = 0.24 μM) and attenuates mitochondrial ATP synthesis. Exhibits antiproliferative activity in a number of leukemias in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 63.00 | |
5 mg | 35 days | $ 210.00 | |
10 mg | 35 days | $ 350.00 | |
50 mg | 35 days | $ 1,300.00 |
Description | NSC 109555 is a selective, reversible, ATP-competitive Chk2 inhibitor (IC50 = 0.2 μM) that displays no effect on a range of other kinases including Chk1 (IC50 > 10 μM). Inhibits histone H1 phosphorylation (IC50 = 0.24 μM) and attenuates mitochondrial ATP synthesis. Exhibits antiproliferative activity in a number of leukemias in vivo. |
Synonyms | NSC-109555, DDUG dimethanesulfonate, NSC109555, DDUG diMS |
Molecular Weight | 600.67 |
Formula | C21H32N10O7S2 |
CAS No. | 15427-93-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NSC 109555 15427-93-7 NSC-109555 DDUG dimethanesulfonate NSC109555 DDUG diMS inhibitor inhibit